MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-BR-26-0054061
Ficus Pharmaceuticals Private Limited
Ficus Pharmaceuticals Private Limited - pharma in Patna, Bihar, India. Directors, charges & compliance details.
Revenue · FY 2025
₹17.01 Lakh
▲ 28% YoY
Net profit · FY 2025
₹4,383
Net margin 0.3%
EBITDA · FY 2025
₹7,405
EBITDA margin 0.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Ficus Pharmaceuticals Private Limited
Data last updated:
Ficus Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 2022.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U85300BR2022PTC059105.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Sandeep Kumar and Manish Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Harish Kumar Sinha At – Sadhanapuri House No F – 7 – 6 – D Gandanibagh, Patna, Bihar, India – 800001.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.01 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹4,383 (net margin 0.3%) and EBITDA of ₹7,405 (EBITDA margin 0.4%).
Ficus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0054061).
Company Details of Ficus Pharmaceuticals Private Limited
CIN U85300BR2022PTC059105
Registration Number 059105
Incorporation Date 21 July 2022
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0054061
Key People
Sandeep Kumar Director Manish Kumar Director Recognitions & Rankings of Ficus Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O – Harish Kumar Sinha At – Sadhanapuri House No F – 7 – 6 – D Gandanibagh, Patna, Bihar, India – 800001
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Ficus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Ficus Pharmaceuticals Private Limited
The main business activity of Ficus Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ficus Pharmaceuticals Private Limited FY 2025 filings available
Ficus Pharmaceuticals Private Limited reported revenue of ₹17.01 Lakh (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹17.01 Lakh ▲ 28%
Net profit · FY 2025
₹4,383 margin 0.3%
EBITDA · FY 2025
₹7,405 margin 0.4%
Compounded Annual Growth Rate (CAGR) of Ficus Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 28%
EBITDA CAGR growth
1 year
▲ 99%
Revenue rose 28% in the latest year. EBITDA rose 99% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Ficus Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹7,405 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4,383 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Ficus Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.4% | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ficus Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ficus Pharmaceuticals Private Limited
Ficus Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar | Director | 21 Jul 2022 | 4 Years 3 Months | Current |
| Manish Kumar | Director | 21 Jul 2022 | 4 Years 3 Months | Current |
Peer Comparison of Ficus Pharmaceuticals Private Limited
Ficus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Celda Pharmaceuticals Private Limited | ₹17.06 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Bangalore, Karnataka, India |
| Hridayam Pharmaceuticals Private Limited | ₹17.05 Lakh (FY 2023) | •••• | •••• | 26.0% | •••• | Zundal, Gujarat, India |
| Treathealth Pharmaceuticals Private Limited | ₹17.04 Lakh (FY 2025) | •••• | •••• | -62.0% | •••• | Aurangabad, Maharashtra, India |
| Eyerest Pharmaceuticals Private Limited | ₹17.03 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Mumbai, Maharashtra, India |
| Mediwing Pharmaceuticals Private Limited | ₹17.02 Lakh (FY 2016) | •••• | •••• | -5.0% | •••• | Ernakulam, Kerala, India |
| Ficus Pharmaceuticals Private Limited this company | ₹17.01 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Patna, Bihar, India |
| Arcana Chemicals Limited | ₹17 Lakh (FY 2024) | •••• | •••• | -96.0% | •••• | Thane, Maharashtra, India |
| Aleafiaa Pharmaceuticals Private Limited | ₹17 Lakh (FY 2024) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Miopass Pharmaceuticals Private Limited | ₹16.99 Lakh (FY 2024) | •••• | •••• | 27.0% | •••• | Lucknow, Uttar Pradesh, India |
| Praxan Pharmaceuticals Private Limited | ₹16.98 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Kolhapur, Maharashtra, India |
| Super Pneumatics Pvt Ltd | ₹16.98 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Ficus Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Ficus Pharmaceuticals Private Limited
Ficus Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ficus Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ficus Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ficus Pharmaceuticals Private Limited
Ficus Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Manish Kumar was appointed as Director on 21 Jul 2022.
AGM
Ficus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ficus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Appointed
Manish Kumar was appointed as Director.
Appointed
Sandeep Kumar was appointed as Director.
Incorporation
21 Jul 2022
Ficus Pharmaceuticals Private Limited was registered on 21 Jul 2022 with Roc Patna & aged 4 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Ficus Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ficus Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ficus Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ficus Pharmaceuticals Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ficus Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ficus Pharmaceuticals Private Limited
Ficus Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 2022 (4+ years old) and is registered under CIN U85300BR2022PTC059105.
Ficus Pharmaceuticals reported revenue of ₹17.01 Lakh for FY 2025 (up 28% YoY).
Ficus Pharmaceuticals has 2 current directors:
- Sandeep Kumar - Director
- Manish Kumar - Director
Ficus Pharmaceuticals reported a net profit of ₹4,383 (net margin 0.3%) and EBITDA of ₹7,405 (EBITDA margin 0.4%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Ficus Pharmaceuticals is U85300BR2022PTC059105. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ficus Pharmaceuticals was incorporated on 21 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Ficus Pharmaceuticals by revenue are Celda Pharmaceuticals Private Limited, Hridayam Pharmaceuticals Private Limited, Treathealth Pharmaceuticals Private Limited, Eyerest Pharmaceuticals Private Limited, Mediwing Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Manish Kumar was appointed as Director on 21 Jul 2022. Sandeep Kumar was appointed as Director on 21 Jul 2022.
Yes, Ficus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0054061).
The registered office of Ficus Pharmaceuticals is at CO – Harish Kumar Sinha At – Sadhanapuri House No F – 7 – 6 – D Gandanibagh, Patna, Bihar, India – 800001.
Ficus Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh.